Biotech

All Articles

8 months after a $213M fundraise, gene publisher Tome produces decreases

.After rearing $213 thousand in 2023-- among the year's largest personal biotech rounds-- Tome Biosc...

BioMarin develops officer staff along with biotech veterinarians-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable management hirings, firings and al...

Biopharma Q2 VC hit highest level due to the fact that '22, while M&ampA reduced

.Financial backing financing right into biopharma rose to $9.2 billion across 215 handle the second ...

Bicara, Zenas seek IPOs to drive late-phase properties towards market

.Bicara Rehabs and also Zenas Biopharma have delivered clean motivation to the IPO market along with...

Genentech to shut cancer cells immunology analysis division

.Genentech will definitely shut its cancer cells immunology study team, as well as unit head and dis...

Kezar goes down strong growth yet to prove its truly worth in phase 1 test

.Kezar Lifestyle Sciences is dropping its unpromising period 1 strong lump medication as the biotech...

Acelyrin drops izokibep, drops 3rd of staff

.Despite izokibep sustaining its newly found winning touch in the clinic, Acelyrin is actually no mo...

Rivus' period 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its own fat-busting, muscle-sparing drug cand...

Ovid standstills preclinical work, IV course after soticlestat fail

.Ovid Therapy presently exposed last month that it was actually trimming back its own head count as ...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has opened a $700 thousand R&ampD center in the Boston Seaport, increasing its RNA as wel...